Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistance

BACKGROUND: The identification and characterization of molecular biomarkers has helped to revolutionize non-small-cell lung cancer (NSCLC) management, as it transitions from target-focused to patient-based treatment, centered on the evolving genomic profile of the individual. Determination of epider...

Descripción completa

Detalles Bibliográficos
Autores principales: Heydt, Carina, Michels, Sebastian, Thress, Kenneth S., Bergner, Sven, Wolf, Jürgen, Buettner, Reinhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880615/
https://www.ncbi.nlm.nih.gov/pubmed/29632655
http://dx.doi.org/10.18632/oncotarget.24624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880615/
https://www.ncbi.nlm.nih.gov/pubmed/29632655
http://dx.doi.org/10.18632/oncotarget.24624

Ejemplares similares